U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07020351) titled 'A Master Protocol of Multiple Interventions for the Treatment of Adults With Moderate-to-Severe Atopic Dermatitis.' on June 06.
Brief Summary: This platform trial is designed to enable the investigation of many interventions for AD by means of the introduction of new interventional specific addenda (ISAs) over time. At the inception of this platform trial, at least 1 ISA will be available. Additional ISAs will be added to the platform trial over time.
Study Start Date: June 21, 2023
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis
Intervention:
DRUG: LY3454738
Administered subcutaneously (SC)
Recruitment Status: TERMI...